Showing 7211-7220 of 9461 results for "".
- ElderDerm Co-Director Suggests Alternatives for 'Senile' in Diagnoseshttps://practicaldermatology.com/news/ElderDerm-Co-Director-Suggests-Alternatives-Senile-Diagnoses/2474689/The word senile can be avoided in discussing dermatologic diseases, Jaya Manjunath, MSIV, asserted at the ElderDerm 2025 Conference in Washington, DC. Manjunath, a medical student and co-director of the conference along with Practical Dermatology editorial board member Adam Friedm
- Hair & Scalp Disorders in Focus at Upcoming Virtual CME Conferencehttps://practicaldermatology.com/news/hair-scalp-disorders-in-focus-at-upcoming-virtual-cme-conference/2474649/Organizers have launched a new CME-accredited conference focused on providing dermatologists insights and strategies for treating hair and scalp disorders in diverse populations. Hair & Scalp Disorders: The Rx Pad & Be
- Dupilumab Improves Clinical and Immunologic Markers in NShttps://practicaldermatology.com/news/dupilumab-improves-clinical-and-immunologic-markers-in-ns/2474591/Results from a recent pilot study suggest an IL-4/IL-13 blockade with dupilumab significantly improved skin and immunologic abnormalities in patients with Netherton syndrome (NS).
- New LED Mask Targets Acne, Redness, Aging in One Sessionhttps://practicaldermatology.com/news/new-led-mask-targets-acne-redness-aging-in-one-session/2474546/Smuuv Body has introduced the Lulu Pro LED Mask in what it says is the first at-home device to deliver five clinically validated wavelengths in a single treatment. A press release from the manufacturer reported that the mask, d
- From ASLMS: Advances in Infantile Hemangioma Diagnosis and Carehttps://practicaldermatology.com/news/from-aslms-advances-in-infantile-hemangioma-diagnosis-and-care/2474328/New guidelines from the International Society for the Study of Vascular Anomalies (ISSVA) offer more precise classification and improved multidisciplinary pathways for patient care. Kristen Kelly, MD, Professor of Dermatology and Surgery a
- FDA Gives Nod to First Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosahttps://practicaldermatology.com/news/fda-gives-nod-to-first-cell-based-gene-therapy-for-recessive-dystrophic-epidermolysis-bullosa/2474382/The U.S. Food and Drug Administration (FDA) has approved ZEVASKYN (prademagene zamikeracel, pz-cel), making it the first cell-based gene therapy for the treatment of wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). The approval addresses a major unmet clinical nee
- RILECSU Study: Rilzabrutinib Effective for Symptoms in Hard-to-Treat Urticariahttps://practicaldermatology.com/news/rilecsu-trial-rilzabrutinib-eases-symptoms-in-hard-to-treat-urticaria/2474350/Rilzabrutinib significantly reduced itch and hives in adults with antihistamine-refractory chronic spontaneous urticaria (CSU), according to new phase 2 trial results published in JAMA Dermatology.
- From ASLMS 2025: Dr. Joel Cohen Highlights New Fractional Laser Techniques, Including Laser-enabled Tissue Coringhttps://practicaldermatology.com/news/from-aslms-dr-joel-cohen-highlights-new-fractional-laser-techniques-for-scars-at-aslms/2474327/During a fractional laser section of the recent program of the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, board-certified dermatologist, Mohs surgeon, and laser expert Joel L. Cohen, MD, FAAD, FACMS, presented clinical insights into fractional laser us
- Study: Laser Therapy Shows Success in HS Management for Skin of Colorhttps://practicaldermatology.com/news/new-study-highlights-laser-therapy-success-in-hs-management-for-skin-of-color/2474344/Fractional ablative CO₂ laser therapy (AFCL) significantly improved hidradenitis suppurativa (HS) outcomes among patients with skin of color, according to a new retrospective study presented at the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual
- From ASLMS 2025: E. Victor Ross, MD, Talks Landscape of Fractional Laser Treatmentshttps://practicaldermatology.com/news/from-aslms-e-victor-ross-md-explores-landscape-of-fractional-laser-treatments/2474326/At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations. Risk, Recovery, and Pigmentatio